Apogee Therapeutics
APGE
#2745
Rank
NZ$10.10 B
Marketcap
NZ$135.41
Share price
-0.77%
Change (1 day)
97.90%
Change (1 year)

Revenue for Apogee Therapeutics (APGE)

Revenue in 2025 (TTM): N/A

a decrease over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Apogee Therapeutics from 2023 to 2025

Annual revenue

Year Revenue Change
2025 N/A
2024 N/A
2023 N/A